Bellevue Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$1.62M Buy
2019
Q1
Sell
2018
Q4
$3.24M Buy
2018
Q3
$3.09M Sell
2018
Q2
$2.5M Sell
2018
Q1
$2.75M Sell
2017
Q4
$3.48M Sell
2017
Q3
$6.63M Sell
2017
Q2
$7.7M Sell
2017
Q1
$12.5M Sell
2016
Q4
$12.7M Buy
2016
Q3
$10.9M Buy
2016
Q2
$8.47M Sell
2016
Q1
$8.76M Buy